The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Gastric Cancer Diagnostic Market Expected To Scale Between 2026 And 2030?
The gastric cancer diagnostic market size has experienced robust growth in recent years. This market is anticipated to expand from $2.78 billion in 2025 to $2.98 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. The expansion observed in the historic period was driven by limited availability of fluorescent probes, reliance on traditional single-color FISH methods, growing genetic research initiatives, increasing hospital and laboratory infrastructure, and adoption of basic cytogenetic diagnostics.
Significant expansion is anticipated for the gastric cancer diagnostic market size over the coming years. By 2030, this market is projected to reach $3.87 billion, demonstrating a compound annual growth rate (CAGR) of 6.8%. This anticipated growth during the forecast period is driven by factors such as the creation of multiplex and high-throughput probes, an increasing need for precision medicine, the broadening scope of genetic and pharmaceutical investigations, innovations in imaging and quantification technologies, and stricter adherence to regulatory compliance and quality benchmarks. Key trends characterizing this period involve the increasing uptake of multiplex and high-throughput FISH probes, the widening application of genetic and molecular diagnostics, their escalating utilization in clinical and pharmaceutical research, the incorporation of advanced imaging and analysis techniques, and an enhanced emphasis on the precision and responsiveness of probes.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27291&type=smp
Which Drivers Are Supporting The Gastric Cancer Diagnostic Market Growth?
The increasing occurrence of gastric cancer is anticipated to drive the expansion of the gastric cancer diagnostic market. Gastric cancer is characterized as a malignant tumor in the stomach lining, where cells proliferate uncontrollably, forming a mass capable of invading adjacent tissues and spreading throughout the body. The elevated incidence of this condition stems from unhealthy dietary practices, as significant consumption of salted, smoked, and processed foods heightens stomach lining damage and cancer risk. Gastric cancer diagnostic tools assist in diagnosis by enabling the early detection of malignant lesions, which is vital for timely intervention and improved patient prognosis. These diagnostics also boost clinical efficiency by delivering precise and rapid results, supporting more effective disease management. For instance, in May 2024, the American Cancer Society, a US-based nonprofit organization, stated that the number of new stomach cancer cases reached 26,890 in 2024, an increase from 26,500 cases in 2023. Therefore, the rising incidence of gastric cancer is directly fueling the growth of the gastric cancer diagnostic market.
How Are Segments Identified Within The Gastric Cancer Diagnostic Market Segment Framework?
The gastric cancer diagnostic market covered in this report is segmented –
1) By Diagnostic Type: Endoscopy, Imaging, Biopsy, Laboratory Tests, Biomarker-Based Testing
2) By Product: Reagents And Consumables, Instruments
3) By Technology: Molecular Diagnostics, Immunoassays, Next-Generation Sequencing, Other Technologies
4) By Application: Early Diagnosis, Screening, Monitoring
5) By End User: Hospitals, Clinics, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Endoscopy: Conventional Endoscopy, Chromoendoscopy, Narrow Band Imaging, Confocal Laser Endomicroscopy, Capsule Endoscopy
2) By Imaging: Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound
3) By Biopsy: Forceps Biopsy, Needle Biopsy, Endoscopic Ultrasound-Guided Biopsy, Laparoscopic Biopsy
4) By Laboratory Tests: Blood Tests, Stool Tests, Urea Breath Test, Serology
5) By Biomarker-Based Testing: Genetic Testing, Protein Biomarker Testing, Circulating Tumor DNA Testing, Microribonucleic Acid Testing
Which Trends Are Expected To Impact The Gastric Cancer Diagnostic Market?
Leading companies in the gastric cancer diagnostic market are concentrating on creating advanced diagnostic instruments, such as artificial intelligence-based endoscopic diagnostic support devices, to improve early detection and precision. These artificial intelligence-based endoscopic diagnostic support devices are AI-driven tools that help identify and evaluate gastrointestinal anomalies during endoscopy. For example, in March 2024, AI Medical Service Inc., a Japan-based medical technology company, introduced GastroAI-model G, an AI-powered endoscopic diagnostic support system. This system aids gastroenterologists during endoscopic procedures by analyzing video images in real time to locate potential cancerous lesions. It leverages deep learning to pinpoint suspicious areas indicative of early gastric cancer, which may require a biopsy or further investigation. When these lesions are found, the system immediately alerts the physician by outlining the area with a rectangle on the endoscopic screen, enhancing diagnostic accuracy and allowing for earlier cancer detection.
Who Are The Companies Competing Within The Gastric Cancer Diagnostic Market?
Major companies operating in the gastric cancer diagnostic market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.
Get The Full Gastric Cancer Diagnostic Market Report:
https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-global-market-report
Which Region Dominates The Gastric Cancer Diagnostic Market By Market Share?
North America was the largest region in the gastric cancer diagnostic market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Gastric Cancer Diagnostic Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=27291&type=smp
Browse Through More Reports Similar to the Global Gastric Cancer Diagnostic Market 2026, By The Business Research Company
Thermal Insulation Material Market Report 2026
https://www.thebusinessresearchcompany.com/report/thermal-insulation-material-global-market-report
Building Insulation Materials Market Report 2026
https://www.thebusinessresearchcompany.com/report/building-insulation-materials-global-market-report
Insulation Products Market Report 2026
https://www.thebusinessresearchcompany.com/report/insulation-products-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model